Review of a Study on the Effect of Sars on Diabetes Mellitus Patients
Hatneiching Haokip3, Prasurjya Saikia*2 Rei Tabom1,
1Scholar of Pharmaceutical Science, Himalayan University , Jollang, village, near central jail, Itanagar, Arunachal Pradesh 791111,India
*2Assistant Professor, Faculty of Pharmaceutical Science, Himalayan University , Jollang, village, near central jail, Itanagar, Arunachal Pradesh 791111,India
3Head of the department , Faculty of Pharmaceutical Science, Himalayan University, Jollang, village, near central jail, Itanagar, Arunachal Pradesh 791111,India
Corresponding Author details-
Prasurjya Saikia
Orcid ID- 0009-0004-3785-5894
Faculty of Pharmaceutical Science, Himalayan University, Jollang, village, near central jail, Itanagar, Arunachal Pradesh 791111, India
E-mail address: prasurjyasaikia17@gmail.com
Abstract
Diabetes mellitus (DM) is among the major global public health issues. According to recent projections, a continued rise in DM prevalence is expected in the following decades. The research has shown that DM is associated with poorer outcomes of coronavirus disease 2019 (COVID-19). However, there is growing evidence suggesting that COVID-19 is associated with new-onset DM type 1 and type 2.
This review aims to summarize the SARS effects the Diabetes Mellitus Patients. Increased risk of poorer COVID-19 outcomes (mechanical ventilation, death) was noted in persons with new-onset DM following SARS-CoV-2 infection. Studies investigating risk factors for SARS on Diabetes Mellitus in COVID-19 patients showed that severe disease, age, ethnicity, ventilation, and smoking habits were associated with DM occurrence. The information summarized in this review presents a valuable source of evidence for healthcare policymakers and healthcare workers in the effort of planning prevention measures for Diabetes Mellitus after SARS-CoV-2 infection and the timely identification and appropriate treatment of patients with Corona Virus who could be at greater risk for new-ones.
